Glenmark Generics Ltd, a division of drug maker Glenmark Pharmaceuticals Ltd, has made announcement about the launching of its anti-hypertension drug ‘Perindopril’ in the UK market.

Glenmark Generics said that it has launched the tablets in three strengths – 2, 4 and 8 mg.

In 2007, the sale for Perindopril tablets, which helps in lowering blood pressure, was 145 million euros in the United Kingdom.

Glenmark Generics’s existing portfolio in the European market consists of two approved products and eight marketing authorisation applications.

At 3:29 p.m., shares of the company gained 1.2% to trade at Rs 304 on the Bombay Stock Exchange (BSE).